Dear Dr. Schutzer
Thank you to you and your team of scientists for this most important research. I am certain you understand the impact this will have on the ME/CFS community, but I want you to know you have my sincerest personal gratitude for all that this research will mean to myself and so many.
As an author, I also want to thank you and the editor, Howard Gendelman at PLos One for allowing open access, so that I may share this across my network.
Celeste Cooper, author,
"Integrative Therapies for Fibromyalgia, Chronic Fatigue Syndrome, and Myofascial Pain: The Mind-Body Connection" (co-author, Jeff Miller, PhD)
Facebook Page: http://www.facebook.com/#!/pages/Integrative-Therapies-for-Fibromyalgia/345295878606
*This note to the lead author was sent in response to the following “breaking news.”
Research Breaks Chronic Fatigue Sterotypes, reported by Katie Couric on CBS news.
The Promise of Proteome Analysis of the PLoS ONE paper by the CFIDS Assoc of America. These markers found in CFS patients’ cerebral spinal fluid could show promise as a biological diagnostic. See the full CAA article on the study Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome, Schutzer et. Al, 2011.
Abstract at Plos One, open access
Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome
Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, Adkins NJ, Camp DG, Holland BK, Bergquist J, Coyle PK, Smith RD, Fallon BA, Natelson BH. (2011) Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome. PLoS ONE 6(2): e17287. doi:10.1371/journal.pone.0017287
Citation: Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, et al. (2011) Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome. PLoS ONE 6(2): e17287. doi:10.1371/journal.pone.0017287
Editor: Howard Gendelman, University of Nebraska, United States of America
Received: November 29, 2010; Accepted: January 26, 2011; Published: February 23, 2011
Copyright: © 2011 Schutzer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: National Institutes of Health, through NIAID (grant AI088765), NIDA (grant DA021071), NINDS (grant NS38636), the National Center for Research Resources (RR018522), the Swedish Research Council (621-2008-3592), Uppsala Berzelii Technology Center for Neurodiagnostics, SciLifeLab-Uppsala, Time for Lyme, Lyme Disease Association, and the Tami Fund for support of portions of the research. Pacific Northwest National Laboratory units are located in the Environmental Molecular Sciences Laboratory, a national scientific user facility, sponsored by the Department of Energy (DOE), operated by Battelle Memorial Institute for the DOE under Contract DE-AC05-76RL0 1830. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: firstname.lastname@example.org
# These authors contributed equally to this work.